Health
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate – Investing.com
U.S. to pay $1 billion for 100 million doses of Johnson & Johnson’s COVID-19 vaccine candidate
By Michael Erman
(Reuters) – The United States government will pay Johnson & Johnson (N:JNJ) over $1 billion for 100 million doses of its potential coronavirus vaccine, as it stocks up on vaccine and drugs in an attempt to tame the pandemic.
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or around $14.50 per dose, including a previous $456 million the U.S. government promised to J&J for vaccine development in March. That compares with the $19.50 per …
-
General23 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News18 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News23 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years